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Spontaneous healing with no or only very mild
ichthyosis distinguishes the ‘‘self-healing collodion
baby’’ from other congenital ichthyoses. In two self-
healing collodion baby siblings with markedly dimin-
ished epidermal transglutaminase 1 activity we found
the compound heterozygous transglutaminase 1 muta-
tions G278R and D490G. Molecular modeling and bio-
chemical assays of mutant proteins under elevated
hydrostatic pressure suggest signi¢cantly reduced activ-
ity in G278R and a chelation of water molecules in
D490G that locks the mutated enzyme in an inactive
trans conformation in utero. After birth these water
molecules are removed and the enzyme is predicted to
isomerize back to a partially active cis form, explaining
the dramatic improvement of this skin condition.
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T
he term ‘‘collodion baby’’ describes an uncommon
and transient condition of the newborn. At birth, af-
fected children are encased in a glistening membrane
that cracks in a characteristic manner within 48 h and
desquamates in large lamellae after a few days leaving
an almost normal appearing skin that shows some scaling on the
trunk. This phenotype can be initially quite severe and often in-
cludes severe ectropion and everted lips (reviewed inTraupe, 1989;
Sybert, 1997). Collodion babies require intensive care, su¡ering
from severe temperature dysregulation and increased insensible
water loss (Buyse et al, 1993). The mortality in the ¢rst weeks of
life is about 10% (Traupe, 1989). Initially, collodion babies look
very much alike at birth, but later take di¡erent clinical courses.
Most patients evolve into the di¡erent types of congenital
ichthyosis such as transglutaminase-1 (TGase1) de¢cient lamellar
ichthyosis (OMIM: 242300), trichothiodystrophy, Sj˛gren^Larsson
syndrome, or Gaucher disease (Lui et al, 1988). About 10% of all
collodion babies heal spontaneously within the ¢rst few weeks
(reviewed in Traupe, 1989; Sybert, 1997). A minority develops dry
skin often present on the trunk only reminiscent of mild forms
of ichthyosis vulgaris (Langer et al, 1991). This condition is called
the self-healing collodium baby (SHCB). In the OMIM catalog
SHCB is listed jointly as lamellar exfoliation of newborn or
desquamation of newborn together with ichthyosis congenita
and lamellar ichthyosis (#242300). In 30%^40% of cases with
autosomal recessive congenital ichthyosis, mutations in theTGM1
gene have been found (Huber et al, 1995; 1997; Lavrijsen and Mar-
uyama, 1995; Parmentier et al, 1995; Russell et al, 1995; Laiho et al,
1997; 1999; Hennies et al, 1998a; Raghunath et al, 1998; Tok et al,
1999; Akiyama et al, 2001; Cserhalmi-Friedman et al, 2001). The
genetic basis of SHCB is not known. In this paper, we describe
a family of SHCB in which two siblings have the same two het-
erozygous mutations inTGM1. One of these mutations is new
and occurs at a novel location that could allow restoration of some
TGase1 activity on drying of the skin several days after birth.
MATERIALS ANDMETHODS
Patients The family originates from Kosovo (formerYugoslavia) and has
an Albanian ethnic background. The nonconsanguineous parents are free
of skin diseases. After 10 miscarriages (each between the twenty-fourth
and thirtieth gestational week) the couple had three daughters. The
youngest daughter, the index case V.S., was seen by one of us at the age of
2 d in the Department of Paediatrics and a biopsy was taken. At that time
point the girl was totally wrapped in a glistening membrane that had
already begun to crack. The girl was seen at the age of 9 d in our
department (Fig 1) with extensive desquamation that was completed
within 2 wk. At 4 wk, the extremities and the face appeared completely
normal. The older sister N.S. (case 2), also born as a collodion baby,
showed mild ¢ne white scaling con¢ned to the trunk at the age of 4 y
when she was seen for the ¢rst time (Fig 1). The clinical diagnosis of
SHCB was made in both. The oldest girl, aged 17 y and healthy, was not
available for clinical examination.
Immunohistochemical localization of TGase1 protein Cryostat
sections were ¢xed in acetone at 201C for 10 min and air dried. Sections
were incubated with the monoclonal antibody BT-621 against human
keratinocyte TGase (Biomedical Technologies, Stoughton, MA) 1: 40 for
16 h at 41C. Bound anti-body was detected in a two-step procedure using
biotinylated goat antimouse 1: 400 for 90 min (Jackson ImmunoResearch
Laboratories,West Grove, PA) and streptavidin DTAF (dto) 1:100 for 30 min.
Histochemical TGase assay The assay (Raghunath et al, 1998) allows
di¡erentiation between full, residual, and lost epidermal activity in skin
cryosections. Four millimeter punch biopsies were taken with informed
parental consent from N.S. at the age of 4 y and fromV.S. at the ages of
2 d and 4 mo. Thirty normal adult skin samples and skin from three
newborns (2 d, 7 d, and 9 d) served as a control group. Brie£y, air-dried
5 mm skin cryosections were incubated with the TGase substrate
biotinylated cadaverine (Molecular Probes, Leiden, The Netherlands) in
Tris bu¡er (pH 7.4 or 8.4) in the presence of calcium ions. Incorporated
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substrate was visualized using streptavidin-DTAF. Images were taken using
a video imaging system and the average exposure time of 1000 ms obtained
for the staining intensity of normal adult skin was applied to all other
experiments with SHCB patients and neonates.
DNA analyses TGM1 mutation screening was performed as reported
earlier (Hennies et al, 1998b) using DNA from ethylenediamine tetraacetic
acid blood of both parents and the two a¡ected daughters. Exons 2^15 of
theTGM1 gene were ampli¢ed by polymerase chain reaction (PCR) using
intronic primers (Philips et al, 1992). PCR products showing single-
stranded conformation polymorphism (SSCP) changes were directly
sequenced on an ABI 377 automatic sequencer.
Structural modeling The three-dimensional model of human TGase1
was generated on the basis of the known atomic structure of human
factor XIIIa (fXIIIa) as present in the protein data bank (Bernstein et al,
1977) under accession number 1F13 (Ichinose et al, 1998). By using the
model building program O (Jones et al, 1991) the sequence of TGase1 was
inscribed onto the structural frame provided by the residues of fXIIIa. The
resulting model for TGase1was then optimized using molecular dynamics.
TGase1 expression and assay Wildtype TGase1 as well as the G278R,
D490G mutants were expressed in and puri¢ed from baculovirus (Candi
et al, 1996). Brie£y, a full-length wildtype human TGase1 cDNA cloned
into the baculovirus vector pVL1392 (PharMingen, San Diego, CA) was
used as a template for the two mutant forms (see Table I) that correspond
to mutations identi¢ed in the SHCB patients. The TransformerTM Site-
directed Mutagenesis Kit (Clontech) was used for introduction of
mutations. The TGase1 cDNAs in the pVL1392 vector were under the
transcriptional control of the strong baculovirus polyhedrin promoter.
The three TGase1 recombinant virus clones (wildtype and two mutant
forms) were obtained by cotransfection of each vector with the modi¢ed
Autographa californica nuclear polyhedrosis virus DNA (BaculoGold DNA,
PharMingen). BaculoGold DNA carries a lethal deletion and does not
code for viable virus particles by itself. Cotransfection of this DNAwith a
complementing plasmid construct rescues the lethal deletion of this virus
DNA and reconstitutes, by homologous recombination, viable virus
particles inside the transfected insect cells. Insect cells (Sf9, PharMingen)
were grown in Grace’s insect medium supplemented with 10% fetal
bovine serum (Life Technologies). Cells were processed as described
recently to obtain separate cytosolic and membrane-bound fractions
(Candi et al, 1998), aliquots of which were used for the TGase assay (Candi
et al, 1998). In some cases, the reaction was performed in a closed vessel
subjected to increased pressure to simulate the higher hydrostatic pressure
in utero in comparison to the ambient environment after birth (Fig 4).
RESULTS
Immunohistochemical detection of TGase1 protein The
visualization of TGase1 as protein revealed a pericellular
distribution in keratinocytes of the uppermost three nucleated
cell layers of the epidermis in normal adults (Fig 2a) and
involvement of up to four cell layers in normal newborns (not
Figure1. Clinical aspects of the two a¡ected siblings with SHCB.
(a) N.S. at the age of 4 y: mild scaling on the trunk. (b) V.S. at the age of
9 d: extensive desquamation and erythroderma.
Table I. Comparison of speci¢c activities of normal and
mutated TGase 1 forms expressed in baculovirus cells at












Speci¢c activities are given as pmol of [14C]putrescine incorporated into succi-
nylated casein/h/pmol of Tgase. Note the striking drop in speci¢c activity at ele-
vated pressure in the D490G mutation.
Figure 2. Immunohistochemical detection of TGase1 protein in
normal skin and SHCB. (a) Normal skin: pericellular linear and contin-
uous localization in the uppermost nucleated two to three keratinocyte
layers. No detection in the corni¢ed layer. (b) V.S. aged 2 d: pericellular
localization in the transitional zone of the granular layer including a hair
follicle. Additional strong signal in most of the thickened corni¢ed layer.
(c) The same child at 4 mo. Distribution pattern comparable to normal skin
involving two to three cell layers of the stratum granulosum. No signi¢-
cant staining in the corni¢ed layer. (d) Four-year-old sister shows distribu-
tion comparable to normal skin with slightly pronounced scaling and
apparent absence of protein in the corni¢ed layer.
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shown) with no immunoreactivity in most of the horny layer.
The SHCB patients V.S. and N.S. showed a comparable pattern
at the age of 4 mo and 4 y, respectively (Fig 2c, d). At 2 d of age,
however, the skin of V.S. showed immunoreactivity restricted to
the uppermost nucleated cell layer and most of the horny layer
(Fig 2b) with a staining intensity comparable to the other skins.
Histochemical TGase activity Skins of normal adults showed
pericellular linear TGase activity con¢ned to the uppermost two
or three nucleated cell layers; neonates showed involvement of
one or two cell layers more (Fig 3a, f, e, j). In contrast to the
immunohistochemical ¢ndings, all SHCB patients showed
alterations in activity and distribution pattern of the enzyme in
comparison to normal skins. In particular, V.S. at the age of 2 d
showed only very faint activity in patchy distribution along the
border between the granular and horny layer (Fig 3b, g). Patchy
activity was also observed in the horny layer (Fig 3b, g). Four
months later, the skin of the same patient showed still patchy
but far stronger activity along the same localization but an addi-
tional thin zone of activity within the horny layer (Fig 3c, h).
The 4-y-old SHCB patient N.S. showed the same pattern as the
4-mo-old sister (Fig 3d, i).
DNA analyses Two point mutations were identi¢ed in exon 5
and 10 by SSCP analysis and subsequent sequencing. A subs-
titution of G byA at position nt 3400 and A to G at position nt
7367 in theTGM1gene leads to the mutations G278R and D490G,
respectively. Both children were compound heterozygous for these
mutations. The father was heterozygous for G278R, and the
mother was heterozygous for D490G (data not shown).
Modeling of the G278R mutation The G278 residue has been
conserved in all TGase enzymes. It resides in the catalytic core
domain near the interface with the b-barrel 1 and 2 domains
(Yee et al, 1994) (Fig 5). The Cb and Cg hydrophobic part of
the much larger mutant arginine side chain packs against
the aromatic ring of Y277 (Y314 in fXIIIa), potentially forms an
Figure 3. Pedigree of SHCB family and visualization of TGase activity in SHCB in comparison with normal adult and newborn skin.
TGase-mediated incorporation of biotinylated cadaverine in cryostat sections was visualized using streptavidin DTAF. The images obtained are arranged
according to the family pedigree. Enlarged details of the upper epidermis are given below the respective image. (a), (f) Normal adult skin: well-de¢ned
pericellular linear activity in a continuous fashion along the granular layer. The activity is spread over two cell layers. (e), (j) Normal 2-d-old newborn:
comparably enhanced activity with a strictly pericellular pattern involving up to four cell layers. (b), (g) SHCB baby at 2 d: faint and patchy activity at the
border between the granular and horny layer. The thickened horny layer shows patches of activity. (c), (h) The skin of the same child at 4 mo shows
enhanced activity along a single cell layer bordering the stratum corneum. Separated by a TGase-negative zone a second layer of activity is found in the
lower stratum corneum. Comparable ¢ndings in the 4 -y-old sister (d, i). Arrows: border between nucleated keratinocytes and horny layer. Bars: 50 mm.
Figure 4. Experimental setting to assess recombinant TGase1 activ-
ity in vitro under pressure. Both the cytosolic form and the enzyme form
bound to insect membranes were used in standard TGase assays. The reac-
tion was performed in a closed vessel. Increased pressure was achieved by app-
lication of pressurized nitrogen and adjusted to a water column of 160 cm
(about 115 mmHg). The reactants were equilibrated at the increased pres-
sure for 10 min, and the reaction was initiated by injection of CaCl2, 5 mM.
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H-bond with the hydroxyl group of Y277, and thereby is likely
to cause considerable local misfolding (Fig 5a). In addition, the
mutant arginine residue may form two improper interactions.
The ¢rst involves a potential H-bond with the backbone
carbonyl oxygen of the conserved L688 (L627 in fXIIIa).
Second, an arginine at position 278 will probably interfere with
the residues R687 and R689 that £ank L688. Together, these are
predicted to derange the linkage between the two b-barrel
domains (Fig 5b) and should explain why the G278R mutation
leads to an inactive enzyme (Table I).
Modeling of the D490G mutation The conserved D490
residue (D427 in fXIIIa) forms a set of complex interactions that
are essential for the proper folding of the catalytic core domain of
TGase1 (Yee et al, 1994). It is immediately preceded by the
nonproline cis peptide bond pair formed by K488/Y489. This cis
bond has likewise been conserved in all TGase enzymes. Thus,
the orientation of D490 is governed by this bond. In addition,
all TGase enzymes have a second cis proline peptide bond pair
formed by residues G473/P474. Together, these two pairs in the
cis con¢guration are essential for the correct three-dimensional
organization of the active site region of the catalytic core
domain (Weiss et al, 1998) (Fig 6). Chelation of several water
molecules through the carbonyl backbone oxygen of K488 with
the backbone nitrogen of Ser476 force the G473/P474 pair to
isomerize to the trans con¢guration, which has been predicted to
inactivate the enzyme (Ichinose et al, 1998). Removal of the waters
will allow isomerization back to the active cis form.Thus,TGase1,
like fXIIIa, is predicted to occur as an equilibrium between the
two forms. The D490 residue forms two sets of H-bonds with (i)
the guanidium nitrogen of R323 and (ii) the nitrogen backbone
of G473. Further, the carbonyl oxygen of G473 forms an H-bond
with R323. Mutation of R323 leads to lamellar ichthyosis (Tok
et al, 1999) and the equivalent residue (R260) in fXIIIa also leads
to disease (Kungsadalampai et al, 1999). Thus, D490 is involved
in a three-dimensional network of H-bonds including the two
essential cis peptide bond pairs. Therefore, the D490G mutations
would be expected to introduce local £exibility and loss of key
H-bonds, and result in some loss of enzyme activity (Table I).
Furthermore, we predict that water molecules will occupy the
cavity created by the smaller side chain of glycine. Modeling
potential electron density maps predicts that water molecules
could chelate with K488 and R323 to form an unusually stabi-
lized inactive trans con¢guration. Thus, under high hydrostatic
water pressure, the D490G mutant enzyme could be inactive,
but under lower pressure conditions removal of the water mole-
cules will reestablish an equilibrium with the cis form and allow
some enzyme activity.
Speci¢c activities of TGase1 mutants Following expression
and puri¢cation, speci¢c activities were measured (Table I).
When the TGase assays were performed under standard solution
conditions, the G278R mutant form was inactive, but the D490G
mutant retained up to 80% of wildtype activity. Under conditions
of increased pressure equivalent to about 115 mmHg, the wildtype
TGase1 activities were generally reduced to 80% (cytosolic) and
70% (bound to insect membranes). This may in part be due to
nonproductive deamidation of the glutamine substrate by water
under conditions of increased pressure. The D490G mutant was
much more sensitive, however, in that the activity was reduced to
40% (cytosolic) and 20% (membrane bound), respectively. In
direct comparison to wildtype TGase1 activity at increased
pressure, the D490G mutant showed residual activities of only
39% (membrane bound) and 22% (cytosolic) (Table I).
DISCUSSION
The benign and self-limited clinical course of SHCB distin-
guishes itself from (TGase1-de¢cient) lamellar ichthyosis. Never-
theless, both conditions are listed under a joint entry number in
the OMIM catalog (#242300) indicating a relation between both
conditions. Accordingly, Langer et al (1991) suggested that SHCB
could represent a minimal expression of lamellar ichthyosis. Our
data, as exempli¢ed with one family, show that this concept is
valid and how this dynamic phenotype can be explained on the
molecular level. From the two compound heterozygousTGM1
mutations in our SHCB family G278R has been reported
Figure 5. Modeling of the G278R mutation. Part of the predicted
three-dimensional structure of TGase1 (based on the fXIIIa modeling) in
the vicinity of the mutation. G278 lies near the interface of the catalytic
core domain and the b-barrel 1 and 2 domains. Insertion of the bulkier
arginine residue will probably cause deformation and allow the formation
of an inappropiate H-bond withY277 (a). Also, the arginine will form H-
bonds with L288 at the interface of the barrels, and thereby interfere with
the required movement during enzyme activation (Yee et al, 1994) (b). These
changes should result in loss of enzyme activity, as revealed by direct assays
of the mutant (Table I).
Figure 6. Modeling of the D490G mutation. This mutation is located
just above the active site/catalytic triad of the core domain. The loss of the
aspartic residue will interfere with the orientation of the two cis G473/P474
and K488/Y489 peptide bonds required for correct folding of this domain
and they will fail to correctly interact with R323.Water molecules can re-
versibly interact with the K488/Y489 residues to £ip the cis bonds (active
enzyme form) over to the trans (inactive enzyme form) con¢guration.We
predict that with the glycine mutant form, additional water molecules in-
troduced under increased hydrostatic pressure could unusually stabilize
the trans con¢guration, resulting in lost activity. In ‘‘dry’’ normal skin this
process reverses, allowing retention of some TGase1 activity (Table I).
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previously in combination with R286Q in a patient with lamel-
lar ichthyosis (Cserhalmi-Friedman et al, 2001). Three-dimen-
sional modeling predicted that the G278R mutant enzyme has
no activity. This was con¢rmed by a direct assay of the speci¢c
activity of the recombinantly expressed mutant enzyme.
Analysis of the novel D490G mutation is more complex. In
part, this residue interacts with R323, which has been reported
mutated in cases of classical lamellar ichthyosis (Tok et al, 1999)
as well as for the equivalent residue in fXIIIa (Kungsadalampai
et al, 1999). More signi¢cantly, our analyses reveal that mutation
of residue D490 could in£uence the normal water molecule
mediated cis^trans isomerization of two cis peptide bond pairs in
the active site region of TGases. In particular, we postulate that,
in the D490G mutant form, water molecules particularly stabilize
the inactive trans form. In support of this idea, we showed that
under normal ambient pressure conditions this mutant retains
about 80% of normal activity, but under increased pressure
conditions wherein more water molecules would be expected to
occupy the space created by the smaller glycine residue the
D490G mutant is almost inactive (Table I).
With respect to the SHCB phenotype we speculate the follow-
ing. In utero, we would expect the average hydrostatic water pres-
sure to be of the order of 100 mmHg, under which conditions
the D490G mutant enzyme might be maximally hydrated and
therefore largely constrained in the inactive trans con¢guration.
Therefore, we would expect that, together with the G278R mu-
tation, the compound heterozygous siblings would have very low
total TGase1 activity, resulting in a collodion membrane pheno-
type at birth consistent with diagnosis of lamellar ichthyosis.
After birth, the skin becomes less hydrated, so that the D490G
mutant enzyme may revert to the partially active cis con¢gura-
tion. This regained TGase1 activity, amounting to upwards of
40% of total normal, may be su⁄cient to sustain a minimal
threshold to allow an improved epidermal phenotype. These
ideas are fully in accord with the observed relative histochemical
improvement of TGase1 activity in the younger patient V.S.
during her ¢rst 4 mo of life, and her older sister N.S. who had
diminished TGase1 activity but with mild pityriasiform scaling
on the trunk. Immunohistochemistry con¢rmed that the reduced
and patchy distribution of TGase1 activity in the granular layer in
both SHCB patients was generally not based on the physical lack
of enzyme.With regard to normal stratum corneum we can only
speculate that the almost complete absence of TGase1 activity and
immunoreactivity is a result of local inactivation or proteolytic
degradation of the enzyme. These processes might be disturbed
in SHCB. Alternatively, the double contoured activity zones in
SHCB might re£ect shedding of mutated TGase1 populations in
di¡erent hydration and thus activity states depending on periodic
changes of skin conditions (local therapy, environmental factors).
In summary, we propose that the reported cases of SHCB are
caused by a novel mutation in theTGM1 gene that a¡ects an im-
portant cis^trans isomerization property of TGase enzymes. The
resulting tardy modi¢cation of the corni¢ed envelope will lead
to clinical manifestation only in the prenatal or immediate peri-
natal period, or when the skin is otherwise challenged. Only
after birth when the skin is exposed for the ¢rst time in life to
air is su⁄cient TGase1 activity acquired to build a more normal
corni¢ed layer.
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